- Home
- PMAX vs GLMD Comparison
PMAX vs GLMD Comparison
Compare PMAX & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- GLMD
- Stock Information
- Founded
- PMAX 2019
- GLMD 2000
- Country
- PMAX Hong Kong
- GLMD Israel
- Employees
- PMAX N/A
- GLMD N/A
- Industry
- PMAX
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- PMAX
- GLMD Health Care
- Exchange
- PMAX Nasdaq
- GLMD Nasdaq
- Market Cap
- PMAX 6.7M
- GLMD 7.5M
- IPO Year
- PMAX 2024
- GLMD 2014
- Fundamental
- Price
- PMAX $0.26
- GLMD $1.38
- Analyst Decision
- PMAX
- GLMD Hold
- Analyst Count
- PMAX 0
- GLMD 1
- Target Price
- PMAX N/A
- GLMD N/A
- AVG Volume (30 Days)
- PMAX 1.9M
- GLMD 218.8K
- Earning Date
- PMAX 10-17-2025
- GLMD 08-28-2025
- Dividend Yield
- PMAX N/A
- GLMD N/A
- EPS Growth
- PMAX N/A
- GLMD N/A
- EPS
- PMAX N/A
- GLMD N/A
- Revenue
- PMAX $4,694,079.00
- GLMD N/A
- Revenue This Year
- PMAX N/A
- GLMD N/A
- Revenue Next Year
- PMAX N/A
- GLMD N/A
- P/E Ratio
- PMAX N/A
- GLMD N/A
- Revenue Growth
- PMAX N/A
- GLMD N/A
- 52 Week Low
- PMAX $0.23
- GLMD $1.15
- 52 Week High
- PMAX $4.70
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- PMAX 31.60
- GLMD 43.92
- Support Level
- PMAX $0.30
- GLMD $1.33
- Resistance Level
- PMAX $0.33
- GLMD $1.63
- Average True Range (ATR)
- PMAX 0.05
- GLMD 0.11
- MACD
- PMAX -0.01
- GLMD 0.00
- Stochastic Oscillator
- PMAX 12.43
- GLMD 35.79
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.